|
Volumn 18, Issue 2, 2005, Pages 44-48
|
In vivo performance of controlled release pellets of diltiazem HCl.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
DILTIAZEM;
VERAPAMIL;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BIOAVAILABILITY;
BLOOD;
CHEMISTRY;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DELAYED RELEASE FORMULATION;
DRUG ADMINISTRATION;
HALF LIFE TIME;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
MALE;
METHODOLOGY;
MICROCAPSULE;
PHARMACOKINETICS;
RANDOMIZED CONTROLLED TRIAL;
STANDARD;
ADULT;
ANTIHYPERTENSIVE AGENTS;
AREA UNDER CURVE;
BIOLOGICAL AVAILABILITY;
CAPSULES;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CROSS-OVER STUDIES;
DELAYED-ACTION PREPARATIONS;
DILTIAZEM;
DRUG ADMINISTRATION SCHEDULE;
HALF-LIFE;
HUMANS;
MALE;
REFERENCE STANDARDS;
THERAPEUTIC EQUIVALENCY;
VERAPAMIL;
|
EID: 33644944142
PISSN: 1011601X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|